SMS Pharma 38th AGM Approves Resolutions via E-Voting

The following seven items of business were transacted at the meeting:

Ordinary Business:

Item 1: Adoption of Audited Standalone and Consolidated Financial Statements for FY 2025-26 and reports of Board of Directors and Auditors (Ordinary Resolution)
Item 2: Declaration of dividend on Equity shares for FY 2025-2026 (Ordinary Resolution)
Item 3: Re-appointment of Dr. Sunkara Venkata Satya Shiva Prasad (DIN: 10404277) who retires by rotation (Ordinary Resolution)

Special Business:

Item 4: Approval of material related party transaction(s) with VKT Pharma Private Limited (Ordinary Resolution)
Item 5: Approval for remuneration payable to the Cost Auditors for FY 2026-27 (Ordinary Resolution)
Item 6: Re-appointment of Mr. Ramesh Babu Potluri (DIN: 00166381) as Chairman and Managing Director and fixation of remuneration (Special Resolution)
Item 7: Approval to provide loan to SMS Peptides Private Limited, Subsidiary Company (Special Resolution)

E-voting facility provided by Central Depository Services (India) Limited (CDSL)
Remote e-voting period: 25th September, 2026 (9:00 a.m.) to 28th September, 2026 (5:00 p.m.)
Remote e-voting also made available during the AGM for members who had not cast votes earlier
E-voting facility kept open for 15 minutes after meeting conclusion

Specific voting results and percentages not provided in this document
The scrutinizer's report and combined results of remote e-voting and e-voting during AGM were to be announced within two working days from meeting conclusion
Results were to be intimated to stock exchanges and placed on company website

Mr. C. Sudhir Babu, Practicing Company Secretary (Membership No: FCS 7666), Proprietor of M/s CSB Associates, Company Secretaries was appointed scrutinizer
Responsible for scrutinizing e-voting process during meeting and through remote e-voting in fair and transparent manner
Mr. Thirumalesh Tumma, Company Secretary was authorized to accept and countersign scrutinizer's report

Meeting conducted in compliance with Companies Act, 2013 and rules thereunder
Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Following circulars issued by Ministry of Corporate Affairs and SEBI
Electronic copy of Annual Report for FY 2025-26 and Notice sent to members by email

Directors Present:

Mr. Ramesh Babu Potluri (Chairman & Managing Director) - Physically present at registered office
Mr. Shravan Kudaravalli (Independent Director & Audit Committee Chairman) - Physically present at registered office
Mr. Sarvepalli Srinivas (Independent Director) - Participated through VC from Noida
Dr. Suresh Kumar Gangavarapu (Independent Director) - Participated through VC from Hyderabad
Mrs. Shanti Sree Bolleni (Independent Director & NRC Chairperson) - Participated through VC from Hyderabad
Mr. Vamsi Krishna Potluri (Executive Director) - Physically present at registered office
Dr. Sunkara Venkata Satya Shiva Prasad (Non-Executive Director & SRC Chairman) - Physically present at registered office
Mr. Trilok Potluri (Non-Executive Director) - Physically present at registered office
Mr. Lakshmi Narayana Tammineedi (CFO) - Physically present at registered office
Mr. Thirumalesh Tumma (Company Secretary) - Physically present at registered office

Other Attendees:

Mr. V. Nagendra Rao (Statutory Auditor, M/s. Suryanarayana & Suresh Chartered Accountants) - Participated through VC from Hyderabad
Mr. A. Venkateswara Rao (Internal Auditor, M/s. Adusumilli and Associates) - Physically present at registered office
Mr. C. Sudhir Babu (Scrutinizer, M/s. CSB Associates) - Physically present at registered office

Company website: www.smspharma.com
Chairman discussed industry scenario, long-term growth, outlook, company performance, challenges, and opportunities
Members were given opportunity to ask questions and seek clarifications on operational and financial performance
Responses provided by Chairman and Executive Directors to member queries